first,orphan,fastTrack,breakthrough,priority,accelerated,initClinicalStudy,therapeuticClass,substanceClass,moleculeType,number,name,ingredients,dateString,use,modeOfAction,innovationCategories,bla,press,trials,unii,pharmacology,target,,Inxight INN Stem,Inxight Target,Inxight ATC level 1,Inxight NPC tags,Inxight Dev Status
,,,,,,?,?,,?,42,Xepi,ozenoxacin,12/11/2017,To treat impetigo,?,?,208945,,,V0LH498RFO,,,Quinolone-derived antibiotics(-oxacin),Bacterial DNA gyrase|Topoisomerase IV,,,"US Unapproved, Marketed"
,,,,,,?,?,protein,?,41,Ozempic,semaglutide,12/5/2017,To improve glycemic control in adults with type 2 diabetes mellitus,?,?,209637,,,53AXN4NNHX,,,Peptides and glycopeptides(-tide),,,,Clinical
1,1,,1,1,,?,?,protein,?,40,Hemlibra,emicizumab,11/16/2017,To prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors,?,?,761083,ucm585567,,7NL2E3F6K3,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,,,Clinical
1,1,1,,1,,?,?,protein,?,39,Mepsevii,vestronidase alfa,11/15/2017,To treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII)- also known as Sly syndrome.,?,?,761047,ucm585308,,7XZ4062R17,,,,,,,Clinical
,,,,,,?,?,protein,?,38,Fasenra,benralizumab,11/14/2017,For add-on maintenance treatment of patients with severe asthma aged 12 years and older- and with an eosinophilic phenotype,?,?,761070,,ucm586076,71492GE1FX,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,,,Clinical
1,1,1,,1,,?,?,chemical,?,37,Prevymis,letermovir,11/8/2017,To prevent infection after bone marrow transplant,?,?,209939,,ucm587123,1H09Y5WO1F,,,Antiviral drug(-vir),Cytomegalovirus|Tripartite terminase subunit UL28 homolog,,,Clinical
,,,,,,?,?,chemical,?,36,Vyzulta,latanoprostene bunod,11/2/2017,To treat intraocular pressure in patients with open-angle glaucoma or ocular hypertension.,?,?,207795,,ucm585409,I6393O0922,,,Prostaglandin analogue(-prost-),,,,Clinical
,1,,1,1,1,?,?,chemical,?,35,Calquence,acalabrutinib,10/31/2017,To treat adults with mantle cell lymphoma,?,?,210259,ucm583076,ucm585780,I42748ELQW,,,Tyrosine-kinase inhibitors(-tinib),Tyrosine-protein kinase BTK,,,Clinical
,1,,1,1,,?,?,gene therapy,?,,Yescarta,axicabtagene ciloleucel,10/18/2017,To treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment,?,?,125643,ucm581216,,U2I8T43Y7R,,,,,,,Clinical
,,1,1,1,,?,?,chemical,?,34,Verzenio,abemaciclib,9/28/2017,To treat certain advanced or metastatic breast cancers,?,?,208716,ucm578071,ucm580765,60UAB198HK,,,,Cyclin-dependent kinase 4|Cyclin-dependent kinase 6,,,Clinical
,,1,,1,,?,?,chemical,?,33,Solosec,secnidazole,9/15/2017,To treat bacterial vaginosis,?,?,209363,,ucm577042,R3459K699K,,,,Trichomonas vaginalis,"ANTIINFECTIVES FOR SYSTEMIC USE|ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",HTS amenable drugs|INN|NPC informatics|NPC screening|QC spectra|Tariff,"US Unapproved, Marketed"
,1,1,,1,1,?,?,chemical,?,32,Aliqopa,copanlisib,9/14/2017,To treat adults with relapsed follicular lymphoma,?,?,209936,ucm576129,ucm577548,WI6V529FZ9,,,,PI3-kinase p110-alpha subunit|PI3-kinase p110-beta subunit|PI3-kinase p110-delta subunit|PI3-kinase p110-gamma subunit,,,"US Unapproved, Marketed"
1,1,,1,1,,?,?,gene therapy,?,,Kymriah,tisagenlecleucel,8/30/2017,To treat certain pediatric and young adult patients with a form of acute lymphoblastic leukemia,?,?,125646,ucm574058,,Q6C9WHR03O,,,,,,,US Approved Rx
,1,,,1,1,?,?,chemical,?,31,benznidazole,benznidazole,8/29/2017,To treat children ages 2 to 12 years old with Chagas disease,?,?,209570,ucm573942,ucm576378,YC42NRJ1ZD,,,,Pyruvate:ferredoxin oxidoreductase,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",ClinicalTrials.gov|HTS amenable drugs|INN|KEGG|NPC informatics|NPC screening|Tariff|WHO essential,US Approved Rx
,,1,,1,,?,?,chemical,?,30,Vabomere,vaborbactam,8/29/2017,To treat adults with complicated urinary tract infections,?,?,209776,ucm573955,ucm576380,1C75676F8V,,,,beta-lactamase activity,,,US Approved Rx
1,1,,1,1,,?,?,protein,?,29,Besponsa,inotuzumab ozogamicin,8/17/2017,To treat adults with relapsed or refractory acute lymphoblastic leukemia,?,?,761040,ucm572131,ucm573493,P93RUU11P7,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,1,1,1,,?,?,chemical,?,28,Mavyret,glecaprevir,8/3/2017,To treat adults with chronic hepatitis C virus,?,?,209394,ucm570038,ucm571769,K6BUU8J72P,,,Antiviral drug(-vir),,,,"US Unapproved, Marketed"
,,1,1,1,,?,?,chemical,?,28,Mavyret,pibrentasvir,8/3/2017,To treat adults with chronic hepatitis C virus,?,?,209394,ucm570038,ucm571769,2WU922TK3L,,,Antiviral drug(-vir),,,,"US Unapproved, Marketed"
1,1,1,,1,,?,?,chemical,?,27,Idhifa,enasidenib,8/1/2017,To treat relapsed or refractory acute myeloid leukemia,?,?,209606,ucm569421,ucm571802,3T1SS4E7AG,,,,"Isocitrate dehydrogenase [NADP], mitochondrial",,,US Approved Rx
,,1,1,1,,?,?,chemical,?,26,Vosevi,voxilaprevir,7/18/2017,To treat adults with chronic hepatitis C virus,?,?,209195,ucm567467,ucm569725,0570F37359,,,Antiviral drug(-vir),,,,US Approved Rx
,,,,,,?,?,chemical,?,25,Nerlynx,neratinib maleate,7/17/2017,To reduce the risk of breast cancer returning,?,?,208051,ucm567309,ucm568138,9RM7XY23ZS,,,,Epidermal growth factor receptor erbB1|Receptor protein-tyrosine kinase erbB-2,,,US Approved Rx
,,,,1,,?,?,protein,?,24,Tremfya,guselkumab,7/13/2017,For the treatment of adult patients with moderate-to-severe plaque psoriasis,?,?,761061,,ucm568274,089658A12D,,,Monoclonal antibodies(-mab),,,,US Approved Rx
,,1,,1,,?,?,chemical,?,23,Bevyxxa,betrixaban,6/23/2017,For the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness,?,?,208383,,ucm567362,74RWP7W0J9,,,Direct Xa inhibitor(-xaban),Coagulation factor X,,,US Approved Rx
,,1,,1,,?,?,chemical,?,22,Baxdela,delafloxacin,6/19/2017,To treat patients with acute bacterial skin infections,?,?,208610,,ucm565472,6315412YVF,,,Quinolone-derived antibiotics(-oxacin),Haemophilus influenzae|Klebsiella pneumoniae|Moraxella catarrhalis|Neisseria gonorrhoeae|Staphylococcus aureus,,INN|NPC informatics,US Approved Rx
,,,,,,?,?,protein,?,21,Kevzara,sarilumab,5/22/2017,To treat adult rheumatoid arthritis,?,?,761037,,ucm562381,NU90V55F8I,,,Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,,,,,?,?,chemical,?,20,Radicava,edaravone,5/5/2017,To treat patients with amyotrophic lateral sclerosis (ALS),?,?,209176,ucm557102,ucm558438,S798V6YJRP,,,,CHEMBL1689064,,Approved drugs|ClinicalTrials.gov|HTS amenable drugs|Human approved drugs|INN|Japan|KEGG|NPC informatics|NPC screening,US Approved Rx
,,,1,1,1,?,?,protein,?,19,Imfinzi,durvalumab,5/1/2017,To treat patients with locally advanced or metastatic urothelial carcinoma,?,?,761069,ucm555930,ucm558005,28X28X9OKV,,,Monoclonal antibodies(-mab),,,,US Approved Rx
,,,,,,?,?,protein,?,18,Tymlos,abaloparatide,4/28/2017,To treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies,?,?,208743,,ucm560331,AVK0I6HY2U,,,Peptides and glycopeptides(-tide),,,,US Approved Rx
1,1,1,1,1,,?,?,chemical,?,17,Rydapt,midostaurin,4/28/2017,To treat acute myeloid leukemia,?,?,207997,ucm555778,ucm557479,ID912S5VON,,,,ETV6-NTRK3|Protein kinase C alpha type|Receptor-type tyrosine-protein kinase FLT3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,HTS amenable drugs|INN|NPC informatics,US Approved Rx
,1,,1,1,1,?,?,chemical,?,16,Alunbrig,brigatinib,4/28/2017,To treat patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib,?,?,208772,,ucm556907,HYW8DB273J,,,Tyrosine-kinase inhibitors(-tinib),ALK tyrosine kinase receptor,,,US Approved Rx
1,1,,1,1,,?,?,protein,?,15,Brineura,cerliponase alfa,4/27/2017,To treat a specific form of Batten disease,?,?,761052,ucm555613,ucm560183,X8R2D92QP1,,,,,,,US Approved Rx
,,1,1,1,,?,?,chemical,?,14,Ingrezza,valbenazine,4/11/2017,To treat adults with tardive dyskinesia,?,?,209241,ucm537040,ucm556168,54K37P50KH,,,Chemical substance(-ine),,,,US Approved Rx
,1,,,,,?,?,chemical,?,13,Austedo,deutetrabenazine,4/3/2017,For the treatment of chorea associated with Huntington’s disease,?,?,208082,,ucm553488,P341G6W9NB,,,Chemical substance(-ine),,,,US Approved Rx
1,,1,1,1,,?,?,protein,?,12,Ocrevus,ocrelizumab,3/28/2017,To treat patients with relapsing and primary progressive forms of multiple sclerosis,?,?,761053,ucm549325,ucm553004,A10SJL62JY,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,,1,1,,?,?,protein,?,11,Dupixent,dupilumab,3/28/2017,To treat adults with moderate-to-severe eczema (atopic dermatitis),?,?,761055,ucm549078,ucm550803,420K487FSG,,,Monoclonal antibodies(-mab),,,,US Approved Rx
,1,1,1,1,,?,?,chemical,?,10,Zejula,niraparib,3/27/2017,"For the maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers",?,?,208447,ucm548948,ucm552068,HMC2H89N35,,,PARP inhibitor(-parib),Poly [ADP-ribose] polymerase 2|Poly [ADP-ribose] polymerase-1,,,US Approved Rx
,,,,,,?,?,chemical,?,9,Symproic,naldemedine,3/23/2017,For the treatment of opioid-induced constipation,?,?,208854,,ucm550343,03KSI6WLXH,,,Chemical substance(-ine),,,,US Approved Rx
,1,1,1,1,1,?,?,protein,?,8,Bavencio,avelumab,3/23/2017,To treat metastatic Merkel cell carcinoma,?,?,761049,ucm548278,ucm551133,KXG2PJ551I,,,Monoclonal antibodies(-mab),,,,US Approved Rx
,,,,,,?,?,chemical,?,7,Xadago,safinamide,3/21/2017,To treat Parkinson’s disease,?,?,207145,ucm547852,ucm552460,90ENL74SIG,,,,Monoamine oxidase B|Sodium channel alpha subunit|glutamate secretion,NERVOUS SYSTEM,HTS amenable drugs|INN|NPC informatics,US Approved Rx
,,,1,1,,?,?,chemical,?,6,Kisqali,ribociclib,3/13/2017,To treat postmenopausal women with a type of advanced breast cancer,?,?,209092,,ucm547960,TK8ERE8P56,,,,Cyclin-dependent kinase 4|Cyclin-dependent kinase 6|IMR-5|SH-SY5Y,,,US Approved Rx
1,1,1,,1,,?,?,chemical,?,5,Xermelo,telotristat ethyl,2/28/2017,To treat carcinoid syndrome diarrhea,?,?,208794,ucm544035,ucm546637,8G388563M7,,,,tryptophan hydroxylase 1,,,US Approved Rx
,,,,,,?,?,protein,?,4,Siliq,brodalumab,2/15/2017,To treat adults with moderate-to-severe plaque psoriasis,?,?,761032,ucm541981,ucm543623,6ZA31Y954Z,,,Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,1,,1,,?,?,chemical,?,3,Emflaza,deflazacort,2/9/2017,To treat patients age 5 years and older with Duchenne muscular dystrophy (DMD),?,?,208684,ucm540945,ucm544351,KR5YZ6AE4B,,,,inflammatory response,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",Approved drugs|Community curation|HTS amenable drugs|Human approved drugs|INN|KEGG|NPC informatics|Tariff|UK NHS,US Approved Rx
,,,,,,?,?,chemical,?,2,Parsabiv,etelcalcetide,2/8/2017,To treat secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing dialysis,?,?,208325,,ucm540898,60ME133FJB,,,Peptides and glycopeptides(-tide),,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",,US Approved Rx
,,,,,,?,?,protein,?,1,Trulance,plecanatide,1/19/2017,To treat Chronic Idiopathic Constipation (CIC) in adult patients,?,?,208745,ucm537725,ucm538309,7IK8Z952OK,,,Peptides and glycopeptides(-tide),,,,US Approved Rx
1,1,1,,1,,?,?,antisense oligo,?,22,Spinraza,nusinersen,12/23/2016,To treat children and adults with spinal muscular atrophy (SMA),?,?,,,,5Z9SP3X666,,,,,,,US Approved Rx
,1,,1,1,1,?,?,chemical,?,21,Rubraca,rucaparib,12/19/2016,To treat women with a certain type of ovarian cancer,?,?,,,,8237F3U7EH,,,PARP inhibitor(-parib),"PARP 1, 2 and 3",,,US Approved Rx
,,,1,,,?,?,chemical,?,20,Eucrisa,crisaborole,12/14/2016,To treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older,?,?,,,,Q2R47HGR7P,,,,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A|cAMP-specific 3',5'-cyclic phosphodiesterase 4B",,,US Approved Rx
1,,1,,1,,?,?,protein,?,19,Zinplava,bezlotoxumab,10/21/2016,To reduce the recurrence of Clostridium difficile infection in patients aged 18 years or older,?,?,,,,4H5YMK1H2E,,,Monoclonal antibodies(-mab),,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,1,1,,1,1,?,?,protein,?,18,Lartruvo,olaratumab,10/19/2016,To treat adults with certain types of soft tissue sarcoma,?,?,,,,TT6HN20MVF,,,Monoclonal antibodies(-mab),,,,US Approved Rx
1,1,1,,1,1,2007,Neurology,antisense oligo,antisense oligo (morpholino),17,Exondys 51,eteplirsen,9/19/2016,To treat patients with Duchenne muscular dystrophy,,,,,,AIW6036FAS,,,,,,,US Approved Rx
,,,,,,2002,Endocrinology,protein,peptide,16,Adlyxin,lixisenatide,7/27/2016,To improve glycemic control (blood sugar levels),,,,,,74O62BB01U,,,Peptides and glycopeptides(-tide),,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,,,,1,,2008,Opthamology,chemical,small molecule,15,Xiidra,lifitegrast,7/11/2016,To treat the signs and symptoms of dry eye disease,,,,,,038E5L962W,,,,,,,US Approved Rx
,,1,1,1,,2012,Infectious disease,chemical,small molecule,14,Epclusa,velpatasvir,6/28/2016,To treat all six major forms of hepatitis C virus,,,,,,KCU0C7RS7Z,,,Antiviral drug(-vir),Nonstructural protein 5A,,,US Approved Rx
,1,,,1,,2013,Oncology,chemical,peptide,13,NETSPOT,gallium 68 dotatate,6/1/2016,A diagnostic imaging agent to detect rare neuroendocrine tumors,labeled somatostatin analogue,,,,,9L17Y0H71P,,,,,,,US Approved Rx
,,,,1,,2003,Oncology,chemical,small molecule,12,Axumin,fluciclovine F 18,5/27/2016,A  new diagnostic imaging agent to detect recurrent prostate cancer,,,,,,38R1Q0L1ZE,,,,,,,US Approved Rx
1,1,1,,1,1,2006,Gastroenterology,chemical,small molecule,11,Ocaliva,obeticholic acid,5/27/2016,"To treat rare, chronic liver disease",bile acid analogue,,,,,0462Z4S4OZ,,,,Bile acid receptor FXR,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,,,,,,1994,Neurology,protein,antibody,10,Zinbryta,daclizumab,5/27/2016,To treat multiple sclerosis,,rescue (orig approval 1997),,,,CUJ2MVI71Y,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Approved drugs|Biologics|EMA human approved|FDA NDC|FDA approved|FDA drugs@FDA|FDA human approved|Human approved drugs|INN|UK NHS,US Approved Rx
,,,1,1,1,2011,Oncology,protein,antibody,9,Tecentriq,atezolizumab,5/18/2016,To treat urothelial carcinoma- the most common type of bladder cancer,,,,,,52CMI0WC3Y,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,,,US Approved Rx
,,,1,1,,2003,Neurology,chemical,small molecule,8,Nuplazid,pimavanserin,4/29/2016,To treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease,,,,,,JZ963P0DIK,,,,Serotonin 2a (5-HT2a) receptor,NERVOUS SYSTEM,,US Approved Rx
1,1,,1,1,1,2011,Oncology,chemical,small molecule,7,Venclexta,venetoclax,4/11/2016,For chronic lymphocytic leukemia in patients with a specific chromosomal abnormality,BCL-2 inhibitor,first-in-class,,,,N54AIC43PW,,,,Apoptosis regulator Bcl-2,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,1,,1,,1999,Hematology,oligonucleotide,polydisperse oligonucleotide,6,Defitelio,defibrotide sodium,3/30/2016,To treat adults and children who develop hepatic veno-occlusive disease with additional kidney or lung abnormalities after they receive a stem cell transplant from blood or bone marrow called hematopoietic stem cell transplantation,,,,,,L7CHH2B2J0,,,Peptides and glycopeptides(-tide),,BLOOD AND BLOOD FORMING ORGANS,Approved drugs|EMA orphan|Human approved drugs|INN|NPC informatics|Structure undefined|Tariff,US Approved Rx
,,,,,,1997,Respiratory,protein,antibody,5,Cinqair,reslizumab,3/23/2016,To treat severe asthma,,,,,,35A26E427H,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,RESPIRATORY SYSTEM,INN|NPC informatics|Structure undefined,US Approved Rx
,,,,,,2008,Rheumatology,protein,antibody,4,Taltz,ixekizumab,3/22/2016,To treat adults with moderate-to-severe plaque psoriasis. ,,,,,,BTY153760O,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,,,,2005,Infectious disease,protein,antibody,3,Anthim,obiltoxaximab,3/18/2016,To treat inhalational anthrax in combination with appropriate antibacterial drugs.,,,,,,29Z5DNL48C,,,Chimeric antibody that responds to more than one antigen(-ximab)|Monoclonal antibodies(-mab),,,,US Approved Rx
,,,,,,2002,Neurology,chemical,small molecule,2,Briviact,brivaracetam,2/18/2016,To treat partial onset seizures in patients age 16 years and older with epilepsy.,,,,,,U863JGG2IA,,,,Synaptic vesicle glycoprotein 2A,NERVOUS SYSTEM,,US Approved Rx
,,,1,1,,2012,Infectious disease,chemical,small molecule,1,Zepatier,grazoprevir,1/28/2016,To treat patients with chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.,,,,,,4O2AB118LA,,,Antiviral drug(-vir),"UniProtKB - Q91RS4, NS3 protease, Hepatitis C virus",,,US Approved Rx
,1,,,,,?,?,chemical,?,44,Uptravi,selexipag,12/22/2015,To treat pulmonary arterial hypertension,?,?,,,,5EXC0E384L,,,,Prostanoid IP receptor|platelet aggregation,BLOOD AND BLOOD FORMING ORGANS,,US Approved Rx
,,,,,,?,?,chemical,?,45,Zurampic,lesinurad,12/22/2015,To treat high blood uric acid levels associated with gout,?,?,,,,09ERP08I3W,,,,Solute carrier family 22 member 11|Solute carrier family 22 member 12,MUSCULO-SKELETAL SYSTEM,,US Approved Rx
1,,,,1,,?,?,chemical,?,43,Bridion,sugammadex,12/15/2015,To reverse effects of neuromuscular blocking drugs used during surgery,?,?,,,,361LPM2T56,,,,CHEMBL1201219|CHEMBL1201244,VARIOUS,,US Approved Rx
,1,,1,1,1,?,?,chemical,?,42,Alecensa,alectinib,12/11/2015,To treat ALK-positive lung cancer,?,?,,,,LIJ4CT1Z3Y,,,Tyrosine-kinase inhibitors(-tinib),ALK tyrosine kinase receptor|SNU-2535,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,1,1,1,,?,?,protein,?,41,Kanuma,sebelipase alfa,12/8/2015,To treat patients with a rare disease known as lysosomal acid lipase (LAL) deficiency,?,?,,,,K4YTU42T8G,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,1,,1,1,,?,?,protein,?,40,Empliciti,elotuzumab,11/30/2015,To treat people with multiple myeloma who have received one to three prior medications,?,?,,,,1351PE5UGS,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,,,,?,?,protein,?,39,Portrazza,necitumumab,11/24/2015,To treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer,?,?,,,,2BT4C47RUI,,,Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,,1,,?,?,chemical,?,38,Ninlaro,ixazomib,11/20/2015,To treat people with multiple myeloma who have received at least one prior therapy,?,?,,,,71050168A2,,,,Proteasome subunit beta type-5,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,"US Unapproved, Marketed"
1,1,1,1,1,1,?,?,protein,?,37,Darzalex,daratumumab,11/16/2015,To treat patients with multiple myeloma who have received at least three prior treatments.,?,?,,,,4Z63YK6E0E,,,Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,1,1,1,?,?,chemical,?,36,Tagrisso,osimertinib,11/13/2015,To treat certain patients with non-small cell lung cancer,?,?,,,,3C06JJ0Z2O,,,Tyrosine-kinase inhibitors(-tinib),Epidermal growth factor receptor,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,,1,,?,?,chemical,?,35,Cotellic,cobimetinib,11/10/2015,"To be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can’t be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation)",?,?,,,,ER29L26N1X,,,Tyrosine-kinase inhibitors(-tinib),Dual specificity mitogen-activated protein kinase kinase 1,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,1,,,,?,?,chemical,?,34,Genvoya,elvitegravir,11/5/2015,For use as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older,?,?,,,,4GDQ854U53,,,Antiviral drug(-vir),Human immunodeficiency virus type 1 integrase,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,,,,,,?,?,protein,?,33,Nucala,mepolizumab,11/4/2015,For use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older.,?,?,,,,90Z2UF0E52,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),Human immunodeficiency virus type 1 integrase,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,,,,,,?,Oncology,oncolytic virus,?,,Imlygic,talimogene laherparepvec,10/27/2015,"Indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery",?,?,125518,ucm469571,,07730V90L6,,,Gene Therapy vectors(-vec),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|RESPIRATORY SYSTEM,Approved drugs|Biologics|EMA orphan|Human approved drugs|INN|NPC informatics,US Approved Rx
1,1,1,1,1,,?,?,protein,?,32,Strensiq,asfotase alfa,10/23/2015,"To treat perinatal, infantile and juvenile-onset hypophosphatasia (HPP).",?,?,,,,Z633861EIM,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,,1,,?,?,chemical,?,31,Yondelis,trabectedin,10/23/2015,To treat specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic).,?,?,,,,ID0YZQ2TCP,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,,,?,?,polymer,?,30,Veltassa,patiromer,10/21/2015,"To treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.",?,?,,,,1FQ2RY5YHH,,,,DNA,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Approved drugs|ClinicalTrials.gov|Community curation|DrugBank v3.0|EMA orphan|HTS amenable drugs|Human approved drugs|NPC informatics|NPC screening,US Approved Rx
1,1,,1,1,1,?,?,protein,?,29,Praxbind,idarucizumab,10/16/2015,For use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa’s blood-thinning effects.,?,?,,,,97RWB5S1U6,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,,,US Approved Rx
,,,,,,?,?,chemical,?,28,Aristada,aripiprazole lauroxil,10/6/2015,To treat adults with schizophrenia,?,?,,,,B786J7A343,,,,,VARIOUS,,US Approved Rx
,,,,,,?,?,protein,?,27,Tresiba,insulin degludec,9/25/2015,To improve blood sugar (glucose) control in adults with diabetes mellitus,?,?,,,,54Q18076QB,,,,Dopamine D2 receptor|Serotonin 1a (5-HT1a) receptor|Serotonin 2a (5-HT2a) receptor,,ClinicalTrials.gov|DrugBank v3.0|FDA DailyMed|FDA NDC|FDA drugs@FDA|FDA orange book|Human approved drugs|Japan|NPC screening|QC spectra,US Approved Rx
,,1,,,,?,?,chemical,?,26,Lonsurf,tipiracil,9/22/2015,To treat patients with an advanced form of colorectal cancer who are no longer responding to other therapies,?,?,,,,NGO10K751P,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,,,?,?,chemical,?,25,Vraylar,cariprazine,9/17/2015,To treat schizophrenia and bipolar disorder in adults,?,?,,,,F6RJL8B278,,,Chemical substance(-ine),Thymidine phosphorylase,,,US Approved Rx
1,1,,1,1,,?,?,chemical,?,24,Xuriden,uridine triacetate,9/4/2015,To treat patients with hereditary orotic aciduria,?,?,,,,2WP61F175M,,,,Dopamine D2 receptor|Dopamine D3 receptor|Serotonin 1a (5-HT1a) receptor|Serotonin 2a (5-HT2a) receptor|Serotonin 2b (5-HT2b) receptor,NERVOUS SYSTEM,,US Approved Rx
,,,,,,?,?,chemical,?,23,Varubi,rolapitant,9/2/2015,To prevent delayed phase chemotherapy-induced nausea and vomiting (emesis),?,?,,,,NLE429IZUC,,,,RNA|Uridine phosphorylase 1|Uridine-cytidine kinase|uridine phosphorylase 2,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,1,,,,,?,?,protein,?,22,Repatha,evolocumab,8/27/2015,To treat certain patients with high cholesterol,?,?,,,,LKC0U3A8NJ,,,Monoclonal antibodies(-mab),Neurokinin 1 receptor|Neurokinin 2 receptor|Neurokinin 3 receptor,ALIMENTARY TRACT AND METABOLISM,Community curation|INN|NPC informatics,US Approved Rx
1,,,,,,?,?,chemical,?,21,Addyi,flibanserin,8/18/2015,"To treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women",?,?,,,,37JK4STR6Z,,,,,CARDIOVASCULAR SYSTEM,,US Approved Rx
,,1,,1,,?,?,chemical,?,20,Daklinza,daclatasvir,7/24/2015,To treat chronic hepatitis C virus (HCV) genotype 3 infections,?,?,,,,LI2427F9CI,,,Antiviral drug(-vir),Dopamine D4 receptor|Serotonin 1a (5-HT1a) receptor|Serotonin 2a (5-HT2a) receptor,GENITO URINARY SYSTEM AND SEX HORMONES,HTS amenable drugs|INN|KEGG|NPC informatics|Tariff,US Approved Rx
,,,,,,?,?,chemical,?,19,Odomzo,sonidegib,7/24/2015,"To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy.",?,?,,,,0RLU3VTK5M,,,,Nonstructural protein 5A,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,,,,,,?,?,protein,?,18,Praluent,alirocumab,7/24/2015,To treat certain patients with high cholesterol,?,?,,,,PP0SHH6V16,,,Monoclonal antibodies(-mab),Smoothened homolog,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,?,?,chemical,?,17,Rexulti,brexpiprazole,7/10/2015,To treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder,?,?,,,,2J3YBM1K8C,,,Proton-pump inhibitor(-prazole),,CARDIOVASCULAR SYSTEM,,US Approved Rx
1,,1,,1,,?,?,chemical,?,16,Entresto,sacubitril,7/7/2015,To treat heart failure,?,?,,,,17ERJ0MKGI,,,,Alpha-1b adrenergic receptor|Alpha-2c adrenergic receptor|Dopamine D2 receptor|Dopamine D3 receptor|Serotonin 1a (5-HT1a) receptor|Serotonin 2a (5-HT2a) receptor|Serotonin 2b (5-HT2b) receptor,NERVOUS SYSTEM,,US Approved Rx
1,1,1,1,1,,?,?,chemical,?,15,Orkambi,lumacaftor,7/2/2015,To treat cystic fibrosis,?,?,,,,EGP8L81APK,,,,Neprilysin,CARDIOVASCULAR SYSTEM,,US Approved Rx
,,,,,,?,?,chemical,?,14,Kengreal ,cangrelor,6/22/2015,To prevent the formation of harmful blood clots in the coronary arteries for adult patients undergoing percutaneous coronary intervention,?,?,,,,6AQ1Y404U7,,,Platelet aggregation inhibitor(-grel-),Cytochrome P450 3A|F508del-CFTR,RESPIRATORY SYSTEM,,US Approved Rx
,,1,,1,,?,?,chemical,?,13,Viberzi,eluxadoline,5/27/2015,To treat irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.,?,?,,,,45TPJ4MBQ1,,,Chemical substance(-ine),,BLOOD AND BLOOD FORMING ORGANS,ClinicalTrials.gov|HTS amenable drugs|INN|KEGG|NPC informatics,US Approved Rx
,,,,,,?,?,chemical,?,12,Kybella,deoxycholic acid,4/29/2015,"To treat adults with moderate-to-severe fat below the chin, known as submental fat",?,?,,,,005990WHZZ,,,,Delta opioid receptor|Mu opioid receptor,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,,1,,1,,?,?,chemical,?,11,Corlanor ,ivabradine,4/15/2015,To reduce hospitalization from worsening heart failure.,?,?,,,,3H48L0LPZQ,,,Chemical substance(-ine),Bile acid receptor FXR|Formyl peptide receptor 1|G-protein coupled bile acid receptor 1|Staphylococcus aureus,DERMATOLOGICALS,Approved drugs|FDA NDC|FDA approved|FDA human approved|Human approved drugs|NPC informatics|Structure undefined,US Approved Rx
,1,,,1,,?,?,chemical,?,10,Cholbam,cholic acid,3/17/2015,"To treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders",?,?,,,,G1JO7801AE,,,,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1|Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2|Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3|Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,CARDIOVASCULAR SYSTEM,Approved drugs|ClinicalTrials.gov|Community curation|HTS amenable drugs|Human approved drugs|INN|NPC screening|Structure undefined|Tariff|UK NHS,Other|US Approved Rx
1,1,,,1,,?,?,protein,?,9,Unituxin,dinutuximab,3/10/2015,To treat pediatric patients with high-risk neuroblastoma,?,?,,,,7SQY4ZUD30,,,Chimeric antibody that responds to more than one antigen(-ximab)|Monoclonal antibodies(-mab),Bile acid receptor FXR,ALIMENTARY TRACT AND METABOLISM,Approved drugs|Community curation|EMA orphan|HTS amenable drugs|Human approved drugs|NPC informatics|NPC screening|QC spectra,US Approved Rx
,1,,,1,,?,?,chemical,?,8,Cresemba,isavuconazonium sulfate,3/6/2015,"To treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections",?,?,,,,31Q44514JV,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,1,,1,,?,?,chemical,?,7,Avycaz,avibactam,2/25/2015,"To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options.",?,?,,,,7352665165,,,,Lanosterol 14-alpha demethylase,,,US Approved Rx
,1,,,1,1,?,?,chemical,?,6,Farydak,panobinostat,2/23/2015,To treat patients with multiple myeloma,?,?,,,,9647FM7Y3Z,,,,Bacterial beta-lactamase TEM,,,US Approved Rx
,1,,,1,,?,?,chemical,?,5,Lenvima,lenvatinib,2/13/2015,"To treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive iodine therapy (radioactive iodine refractory disease).",?,?,,,,EE083865G2,,,Tyrosine-kinase inhibitors(-tinib),Histone deacetylase 1|Histone deacetylase 2|Histone deacetylase 3|Histone deacetylase 4|Histone deacetylase 6|Histone deacetylase 8,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,,1,1,1,?,?,chemical,?,4,Ibrance,palbociclib,2/3/2015,To treat advanced (metastatic) breast cancer,?,?,,,,G9ZF61LE7G,,,,Fibroblast growth factor receptor 1|Fibroblast growth factor receptor 2|Fibroblast growth factor receptor 3|Platelet-derived growth factor receptor beta|Stem cell growth factor receptor|Vascular endothelial growth factor receptor 1|Vascular endothelial growth factor receptor 2|Vascular endothelial growth factor receptor 3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,,,,?,?,protein,?,3,Natpara,parathyroid hormone,1/23/2015,To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism,?,?,,,,N19A0T0E5J,,,,CDK4/Cyclin D3|CDK6/cyclin D2|Cyclin-dependent kinase 4/cyclin D1|MDA-MB-175-VII|ZR-75-30,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,,,,,?,?,protein,?,2,Cosentyx,secukinumab,1/21/2015,To treat adults with moderate-to-severe plaque psoriasis,?,?,,,,DLG4EML025,,,Monoclonal antibodies(-mab),,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",Approved drugs|Biologics|Canada|Human approved drugs|INN|NPC informatics|Structure undefined|UK NHS,US Approved Rx
,,,,,,?,?,chemical,?,1,Savaysa,edoxaban,1/8/2015,To reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem,?,?,,,,NDU3J18APO,,,Direct Xa inhibitor(-xaban),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,1,1,1,?,?,protein,antibody,41,Opdivo,nivolumab,12/22/2014,To treat patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs,PD-1 inhibitor,Pembrolizumab and Nivolumab are first to target PD-1,,,,31YO63LBSN,,,Monoclonal antibodies(-mab),Coagulation factor X,BLOOD AND BLOOD FORMING ORGANS,,US Approved Rx
1,1,,,1,1,2005,?,chemical,small molecule,37,Lynparza,olaparib,12/19/2014,To treat advanced ovarian cancer,PARP inhibitor,novel; first approved against this target,,,,WOH1JD9AR8,,,PARP inhibitor(-parib),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,1,1,1,,?,?,chemical,small molecule,38,Viekira Pak,ombitasvir,12/19/2014,"To treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis","NS5A, NS3/4A, NS5B polymerase inhibitor",Same approach as other anti-HCV therapies,,,,2302768XJ8,,,Antiviral drug(-vir),Poly [ADP-ribose] polymerase 1|Poly [ADP-ribose] polymerase 2|Poly [ADP-ribose] polymerase 3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,1,,1,,?,?,chemical,small molecule,39,Zerbaxa,ceftolozane,12/19/2014,To treat adults with complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI),Cephalosporin/beta-lactamase inhibitor,Similar to many,,,,37A4IES95Q,,,Cephem-type antibiotics(cef-),Nonstructural protein 5A,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,,1,,,,?,?,chemical,small molecule,40,Rapivab,peramivir,12/19/2014,To treat influenza infection in adults,Neuraminidase inhibitor,Similar to oseltamivir,,,,QW7Y7ZR15U,,,Antiviral drug(-vir),Bacterial penicillin-binding protein,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,,1,1,1,,?,?,chemical,small molecule,38,Viekira Pak,paritaprevir,12/19/2014,"To treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis","NS5A, NS3/4A, NS5B polymerase inhibitor",Same approach as other anti-HCV therapies,,,,OU2YM37K86,,,Antiviral drug(-vir),Influenza A virus infection|Influenza Infection|UNIPROT:NRAM_I96A1,,KEGG|NPC informatics|Structure undefined,US Approved Rx
1,,1,1,1,,?,?,chemical,small molecule,38,Viekira Pak,dasabuvir,12/19/2014,"To treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis","NS5A, NS3/4A, NS5B polymerase inhibitor",Same approach as other anti-HCV therapies,,,,DE54EQW8T1,,,Antiviral drug(-vir),,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,,,,1,,2007,?,chemical,small molecule,36,Xtoro,finafloxacin,12/17/2014,"To treat acute otitis externa, commonly known as swimmer’s ear",Topoisomerase and DNA gyrase inhibition,Similar to other fluoroquinolone antibiotics,,,,D26OSN9Q4R,,,Quinolone-derived antibiotics(-oxacin),polyprotein,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,1,,1,1,1,2002,?,protein,bispecific antibody,35,Blincyto,blinatumomab,12/3/2014,To treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL),CD19 and CD3 targeted,novel; CD19 is novel and mode is novel in directing the human immune system to act against tumor B cells,,,,4FR53SIF3A,,,Monoclonal antibodies(-mab),DNA gyrase subunit A|DNA topoisomerase IV subunit A,,INN|NPC informatics|Structure undefined,US Approved Rx
1,1,1,1,1,,2004,?,chemical,small molecule,33,Ofev,nintedanib,10/15/2014,For the treatment of idiopathic pulmonary fibrosis (IPF),"VEGF, FGFR, and PDGFR inhibitor",perhaps novel use of kinase inhibitor for indication,,,,G6HRD2P839,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,1,1,1,,?,?,chemical,small molecule,34,Esbriet,pirfenidone,10/15/2014,For the treatment of idiopathic pulmonary fibrosis (IPF),Unknown,novel; systemic antifibrotic activity,,,,D7NLD2JX7U,,,,Vascular endothelial growth factor receptor 1|Vascular endothelial growth factor receptor 2|Vascular endothelial growth factor receptor 3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,1,1,1,,?,?,chemical,small molecule,30,Harvoni,ledipasvir,10/10/2014,To treat chronic hepatitis C virus (HCV) genotype 1 infection,NS5A inhibitor/polymerase inhibitor,Same approach as other anti-HCV therapies,,,,013TE6E4WV,,,Antiviral drug(-vir),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Approved drugs|ClinicalTrials.gov|EMA orphan|HTS amenable drugs|Human approved drugs|INN|Japan|KEGG|NPC screening|QC spectra,US Approved Rx
,,,,,,2007,?,chemical,small molecule,31,Akynzeo,netupitant,10/10/2014,To treat nausea and vomiting in patients undergoing cancer chemotherapy,NK1 substance P receptor antagonist/5-HT3 receptor antagonist,Similar to aprepitant/setrons,,,,7732P08TIR,,,,Nonstructural protein 5A,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,,,,,,?,?,chemical,small molecule,32,Lumason,sulfur hexafluoride,10/10/2014,For patients whose ultrasound image of the heart (echocardiograms) are hard to see with ultrasound waves,Contrast imaging agent,"Similar to SonoVue, Optison and other contrast agents for ultrasound",,,,WS7LR3I1D6,,,,Substance-P receptor,,HTS amenable drugs|INN|NPC informatics,US Approved Rx
,,,,,,?,?,protein,peptide,29,Trulicity,dulaglutide,9/18/2014,To treat adults with type 2 diabetes.,GLP-1 receptor agonist,"Similar to exenatide, etc.",,,,WTT295HSY5,,,Peptides and glycopeptides(-tide),,VARIOUS,Approved drugs|EMA human approved|FDA NDC|FDA approved|FDA human approved|Human approved drugs|Inorganics|NPC informatics,"US Unapproved, Marketed"
,,,,,,2007,?,chemical,small molecule,28,Movantik,naloxegol,9/16/2014,To treat opioid-induced constipation in adults with chronic non-cancer pain.,Peripherally selective opioid antagonist,Incremental improvement; PEGlated naloxone,,,,44T7335BKE,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,1,,1,1,1,?,?,protein,antibody,27,Keytruda,pembrolizumab,9/4/2014,For treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs.,PD-1 inhibitor,Pembrolizumab and Nivolumab are first to target PD-1,,,,DPT0O3T46P,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),Mu-type opioid receptor,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,1,,,1,,?,?,chemical,small molecule,26,Cerdelga,eliglustat,8/19/2014,For the long-term treatment of adult patients with the Type 1 form of Gaucher disease,Glucosylceramide synthase inhibitor,Similar to miglustat,,,,DR40J4WA67,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,2006,?,protein,PEGlated protein,25,Plegridy,peginterferon beta-1a,8/15/2014,For the treatment of patients with relapsing forms of multiple sclerosis,Unknown,Incremental Improvement; PEGlated interferon beta-1a,,,,I8309403R0,,,,Ceramide glucosyltransferase,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,,,,,,2007,?,chemical,small molecule,24,Belsomra,suvorexant,8/13/2014,To treat difficulty in falling and staying asleep (insomnia),Orexin receptor antagonist,novel; first approved against this target,,,,081L192FO9,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,1,,?,?,chemical,glycopeptide,23,Orbactiv,oritavancin,8/6/2014,To treat adults with skin infections,Cell membrane disrupter,"Similar to others, a 2nd generation vancomycin",,,,PUG62FRZ2E,,,,Orexin receptor type 1|Orexin receptor type 2,,,US Approved Rx
,,,,,,2008,?,chemical,small molecule,22,Jardiance,empagliflozin,8/1/2014,To improve gylcemic control in adults with type 2 diabetes,SGLT2 inhibitor,Similar to dapagliflozin and canagliflozin,,,,HDC1R2M35U,,,,Enterococcus faecium|Peptidoglycan|Staphylococcus aureus|Streptococcus pyogenes,ANTIINFECTIVES FOR SYSTEMIC USE,Biologics|ClinicalTrials.gov|INN|NPC informatics,US Approved Rx
,,,,,,2006,?,chemical,small molecule,21,Striverdi Respimat,olodaterol,7/31/2014,To treat chronic obstructive pulmonary disease,LABA agonist,"Similar to Salmeterol, Formoterol, Bambuterol",,,,VD2YSN1AFD,,,,Sodium/glucose cotransporter 2,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
1,1,1,1,1,1,2008,?,chemical,small molecule,20,Zydelig,idelalisib,7/23/2014,"(1) Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities; and (2) Relapsed small lymphocytic lymphoma (SLL) in patients who have received at least two prior systemic therapies; (3) Relapsed follicular B-cell non-Hodgkin lymphoma (FL) in patients who have received at least two prior systemic therapies.",PI3K delta inhibitor,novel; first approved against this target,,,,YG57I8T5M0,,,,Beta-2 adrenergic receptor,RESPIRATORY SYSTEM,,US Approved Rx
1,,,,,,?,?,chemical,small molecule,19,Kerydin,tavaborole,7/7/2014,For the topical treatment of onychomycosis of the toenails ,tRNA synthetase inhibition,Similar to mupirocin and furanomycin; http://www.sciencedirect.com/science/article/pii/S221132071300016X,,,,K124A4EUQ3,,,,PI3-kinase p110-delta subunit,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,,1,1,?,?,chemical,small molecule,18,Beleodaq,belinostat,7/3/2014,To treat patients with peripheral T-cell lymphoma (PTCL) ,pan-HDAC inhibitor,Similar to SAHA and other HDACis,,,,F4H96P17NZ,,,,ENTREZ Gene ID: 10373705|ENTREZ Gene ID: 10373871,,,US Approved Rx
,,,,1,,?,?,chemical,small molecule,17,Sivextro,tedizolid phosphate,6/20/2014,To treat adults with skin infections,Bacterial protein synthesis inhibitor,Similar to linezolid and cycloserine,,,,O7DRJ6R4DW,,,,Histone deacetylase 1|Histone deacetylase 3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,?,?,chemical,small molecule,16,Jublia,efinaconazole,6/6/2014,Treat mild to moderate onychomycosis (fungal infection),14α-Demethylase inhibitor,Similar to other azole antifungals,,,,J82SB7FXWB,,,,Bacterial 70S ribosome,,,US Approved Rx
,,1,,1,,?,?,chemical,glycopeptide,15,Dalvance,dalbavancin ,5/23/2014,To treat adults with skin infections,Cell wall synthesis inhibition,"Similar to others, a 2nd generation vancomycin",,,,808UI9MS5K,,,,Lanosterol 14-alpha demethylase,DERMATOLOGICALS,,US Approved Rx
,,1,,1,,1997,?,protein,antibody,14,Entyvio,vedolizumab,5/20/2014,To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease,Integrin receptor antagonist,novel; targets Integrin α4β7,,,,9RV78Q2002,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),Peptidoglycan,ANTIINFECTIVES FOR SYSTEMIC USE,Biologics|INN|NPC informatics,US Approved Rx
1,,1,,,,2004,?,chemical,small molecule,13,Zontivity,vorapaxar,5/8/2014,To reduce the risk of heart attacks and stroke in high-risk patients,PAR-1 antagonist,novel target; PAR-1 antagonist,,,,ZCE93644N2,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,1,1,1,?,?,chemical,small molecule,12,Zykadia,ceritinib,4/29/2014,To treat patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib,ALK inhibitor,Similar to others; crizotinib seems to have similar kinase profile,,,,K418KG2GET,,,Tyrosine-kinase inhibitors(-tinib),Proteinase-activated receptor 1,BLOOD AND BLOOD FORMING ORGANS,,US Approved Rx
1,1,,,1,,1998,?,protein,antibody,11,Sylvant,siltuximab,4/23/2014,"To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)",IL-6 inhibitor,"novel target, but just upstream of Tocilizumab",,,,T4H8FMA7IM,,,Chimeric antibody that responds to more than one antigen(-ximab)|Monoclonal antibodies(-mab),ALK tyrosine kinase receptor,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,,1,,2005,?,protein,antibody,10,Cyramza,ramucirumab,4/21/2014,To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma,VEGFR2 inhibitor,novel; VEGF and VEGFR1 anitbodies exist,,,,D99YVK4L0X,,,Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,?,?,protein,peptide,9,Tanzeum,albiglutide,4/15/2014,"To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes",GLP-1 receptor agonist,"Similar to exenatide, etc.",,,,5E7U48495E,,,Peptides and glycopeptides(-tide),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,,,,,2003,?,chemical,small molecule,8,Otezla,apremilast,3/21/2014,To treat adults with active psoriatic arthritis (PsA),PDE4 inhibitor,novel; no other PDE4 inhibitor seems to have activity in arthritis (Roflumilast is approved for COPD),,,,UP7QBP99PN,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,,,?,?,chemical,small molecule,6,Neuraceq,florbetaben F 18,3/19/2014,For Positron EmissionTomography (PET) imaging of the brain,Radioactive diagnostic,novel; AD plaque imaging,,,,TLA7312TOI,,,,Phosphodiesterase 4,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,Other|US Approved Rx
1,1,1,,1,,?,?,chemical,phospholipid,7,Impavido,miltefosine,3/19/2014,To treat a tropical disease called leishmaniasis,Unknown,novel; various effects incl on AKT,,,,53EY29W7EC,,,Chemical substance(-ine),Amyloid beta A4 protein,VARIOUS,,US Approved Rx
1,1,1,,1,,1999,?,protein,peptide,5,Myalept,metreleptin,2/24/2014,To treat the complications of leptin deficiency,Leptin receptor activation,novel; leptin not previously approved,,,,TL60C27RLH,,,,UNIPROT: B7TYN7,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Approved drugs|ClinicalTrials.gov|EMA orphan|HTS amenable drugs|Human approved drugs|INN|KEGG|NPC screening|QC spectra|Tariff,US Approved Rx
1,1,1,,1,1,?,?,chemical,small molecule,4,Northera,droxidopa,2/18/2014,To treat neurogenic orthostatic hypotension (NOH),Prodrug of norepinephrine and epinephrine,"Incremental improvement, BBB-penetrant prodrug/precursor",,,,J7A92W69L7,,,,,ALIMENTARY TRACT AND METABOLISM,INN|NPC informatics|Structure undefined,US Approved Rx
1,1,1,,1,,?,?,protein,enzyme,3,Vimizim,elosulfase alfa,2/14/2014,Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome),Enzyme replacement therapy,novel enzyme replacement therapy,,,,ODJ69JZG85,,,,Adrenergic receptor,CARDIOVASCULAR SYSTEM,Approved drugs|ClinicalTrials.gov|Community curation|DrugBank v3.0|HTS amenable drugs|Human approved drugs|INN|Japan|KEGG|NPC screening,US Approved Rx
,1,,,1,,2006,?,chemical,small molecule,2,Hetlioz,tasimelteon,1/31/2014,To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.,Melatonin receptor agonist,"Similar to Melatonin, Ramelteon, Agomelatine",,,,SHS4PU80D9,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,,,2008,?,chemical,small molecule,1,Farxiga,dapagliflozin,1/8/2014,"To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes",SGLT2 inhibitor,"Similar to empagliflozin, canagliflozin, ipragliflozin",,,,1ULL0QJ8UC,,,,Melatonin receptor type 1A|Melatonin receptor type 1B,NERVOUS SYSTEM,Community curation|INN|NPC informatics,US Approved Rx
,,,,,,?,?,chemical,?,27,Anoro Ellipta,umeclidinium,12/18/2013,"For the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).",?,?,,,,GE2T1418SV,,,,Sodium/glucose cotransporter 2,ALIMENTARY TRACT AND METABOLISM|DRUGS USED IN DIABETES,INN|NPC informatics,US Approved Rx
1,,1,1,1,,2007,?,chemical,?,26,Sovaldi,sofosbuvir,12/6/2013,To treat chronic hepatitis C virus (HCV) infection.,?,?,,,,WJ6CA3ZU8B,,,Antiviral drug(-vir),Muscarinic acetylcholine receptor M3,RESPIRATORY SYSTEM,,US Approved Rx
,,1,,1,,2007,?,chemical,?,25,Olysio,simeprevir,11/22/2013,To treat chronic hepatitis C virus infection.,?,?,,,,9WS5RD66HZ,,,Antiviral drug(-vir),Acyl coenzyme A:cholesterol acyltransferase|Hepatitis C virus|Lysosomal protective protein,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,,,,,,?,?,chemical,?,24,Luzu,luliconazole,11/14/2013,"For the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older.",?,?,,,,RE91AN4S8G,,,,Q91RS4_9HEPC,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,1,1,1,1,1,2009,?,chemical,?,23,Imbruvica,ibrutinib,11/13/2013,"To treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer.",?,?,,,,1X70OSD4VX,,,Tyrosine-kinase inhibitors(-tinib),,DERMATOLOGICALS,,Other|US Approved Rx
,,,,,,2000,?,chemical,?,22,Aptiom,eslicarbazepine acetate,11/8/2013,As an add-on medication to treat seizures associated with epilepsy.,?,?,,,,BEA68ZVB2K,,,,Tyrosine-protein kinase BTK,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,1,1,,2008,?,protein,?,21,Gazyva,obinutuzumab,11/1/2013,For use in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL).,?,?,,,,O43472U9X8,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),Sodium channel alpha subunit,,INN|NPC informatics|Structure undefined,US Approved Rx
,,,,,,?,?,chemical,?,20,Vizamyl,flutemetamol F-18,10/25/2013,A radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer's disease (AD) and dementia.,?,?,,,,L49M066S0O,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,,,,2003,?,chemical,?,19,Opsumit,macitentan,10/18/2013,"To treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.",?,?,,,,Z9K9Y9WMVL,,,,Amyloid beta A4 protein,VARIOUS,,US Approved Rx
1,1,,,1,,2005,?,chemical,?,18,Adempas,riociguat,10/8/2013,To treat adults with two forms of pulmonary hypertension.,?,?,,,,RU3FE2Y4XI,,,,Endothelin B receptor|Endothelin-1 receptor,CARDIOVASCULAR SYSTEM,,US Approved Rx
,,,,,,?,?,chemical,?,17,Duavee,bazedoxifene,10/3/2013,To treat moderate-to-severe hot flashes (vasomotor symptoms) associated with menopause and to prevent osteoporosis after menopause.,?,?,,,,Q16TT9C5BK,,,,Soluble guanylate cyclase,CARDIOVASCULAR SYSTEM,,US Approved Rx
,,,,,,?,?,chemical,?,16,Brintellix,vortioxetine,9/30/2013,To treat adults with major depressive disorder.,?,?,,,,3O2K1S3WQV,,,Antidepressant related to fluoxetine(-oxetine)|Chemical substance(-ine),Estrogen receptor|Estrogen receptor beta,GENITO URINARY SYSTEM AND SEX HORMONES,ClinicalTrials.gov|HTS amenable drugs|KEGG|NPC informatics|NPC screening,US Approved Rx
,,1,,1,,2007,?,chemical,?,15,Tivicay,dolutegravir,8/12/2013,To treat HIV-1 infection.,?,?,,,,DKO1W9H7M1,,,Antiviral drug(-vir),5-hydroxytryptamine receptor 1A|5-hydroxytryptamine receptor 1B|5-hydroxytryptamine receptor 1D|5-hydroxytryptamine receptor 3A|5-hydroxytryptamine receptor 7,NERVOUS SYSTEM,,US Approved Rx
,1,1,,1,,2004,?,chemical,?,14,Gilotrif,afatinib,7/12/2013,"For patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.",?,?,,,,41UD74L59M,,,Tyrosine-kinase inhibitors(-tinib),UNIPROT: Q7ZJM1,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,1,1,,,,?,?,chemical,?,12,Tafinlar,dabrafenib,5/29/2013,To treat patients with melanoma whose tumors express the BRAF V600E gene mutation.,?,?,,,,QGP4HA4G1B,,,,Epidermal growth factor receptor|Receptor tyrosine-protein kinase erbB-2|Receptor tyrosine-protein kinase erbB-4,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,1,,,,2008,?,chemical,?,13,Mekinist,trametinib,5/29/2013,To treat patients whose tumors express the BRAF V600E or V600K gene mutations.,?,?,,,,33E86K87QN,,,Tyrosine-kinase inhibitors(-tinib),Serine/threonine-protein kinase B-raf,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,1,,1,,?,?,chemical,?,11,Xofigo,radium Ra 223 dichloride,5/15/2013,To treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.,?,?,,,,RJ00KV3VTG,,,,Dual specificity mitogen-activated protein kinase kinase 1|Dual specificity mitogen-activated protein kinase kinase 2,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,?,?,chemical,?,10,Breo Ellipta,vilanterol,5/10/2013,"For the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.",?,?,,,,028LZY775B,,,,,,,US Approved Rx
1,,,,,,2006,?,chemical,?,9,Invokana,canagliflozin,3/29/2013,"Used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.",?,?,,,,0SAC974Z85,,,,"adrenoceptor beta 2, surface",RESPIRATORY SYSTEM,,US Approved Rx
1,,,,,,1999,?,chemical,?,8,Tecfidera,dimethyl fumarate,3/27/2013,To treat adults with relapsing forms of multiple sclerosis (MS).,?,?,,,,FO2303MNI2,,,,Sodium/glucose cotransporter 2,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,1,,?,?,chemical,?,7,Dotarem,gadoterate meglumine,3/20/2013,"For use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.",?,?,,,,L0ND3981AG,,,Chemical substance(-ine),,NERVOUS SYSTEM,,US Approved Rx
,,,,,,?,?,polymer,?,6,Lymphoseek,technetium Tc 99m tilmanocept,3/13/2013,A radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.,?,?,,,,8IHI69PQTC,,,,,,ClinicalTrials.gov|Community curation|DrugBank v3.0|EMA human approved|FDA DailyMed|FDA orange book|Human approved drugs|Inorganics|Japan|Structure undefined,US Approved Rx
,,,,,,2001,?,chemical,?,5,Osphena,ospemifene,2/26/2013,"To treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.",?,?,,,,B0P231ILBK,,,,Macrophage mannose receptor 1,VARIOUS,,US Approved Rx
1,,1,,1,,2006,?,protein,?,4,Kadcyla,ado-trastuzumab emtansine,2/22/2013,"For patients with HER2-positive, late-stage (metastatic) breast cancer.",?,?,,,,SE2KH7T06F,,,Chemical substance(-ine),Estrogen receptor|Estrogen receptor beta,GENITO URINARY SYSTEM AND SEX HORMONES,Community curation|HTS amenable drugs|INN|NPC informatics,US Approved Rx
,1,1,,,1,?,?,chemical,?,3,Pomalyst,pomalidomide,2/8/2013,To treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.,?,?,,,,D2UX06XLB5,,,,Receptor tyrosine-protein kinase erbB-2,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,1,,,,,2003,?,antisense oligo,?,2,Kynamro,mipomersen sodium,1/29/2013,To treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).,?,?,,,,18EAY4870E,,,,tumor necrosis factor,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,?,?,chemical,?,1,Nesina,alogliptin,1/25/2013,To improve blood sugar control in adults with type 2 diabetes.,?,?,,,,JHC049LO86,,,,,,,US Approved Rx
1,,1,,1,,1993,?,polymer,?,39,Fulyzaq,crofelemer,12/31/2012,"To treat HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite.",?,?,,,,PY79D6C8RX,,,,Dipeptidyl peptidase 4,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,1,,2004,?,chemical,?,37,Eliquis,apixaban,12/28/2012,To reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.,?,?,,,,3Z9Y7UWC1J,,,Direct Xa inhibitor(-xaban),Anoctamin-1|Cystic fibrosis transmembrane conductance regulator,,HTS amenable drugs|INN|KEGG|NPC informatics,US Approved Rx
1,1,,,1,1,?,?,chemical,?,38,Sirturo,bedaquiline,12/28/2012,As part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available.,?,?,,,,78846I289Y,,,Chemical substance(-ine),Coagulation factor X,BLOOD AND BLOOD FORMING ORGANS,KEGG|NPC informatics|Structure undefined|USAN,US Approved Rx
1,1,,,,,1998,?,protein,?,35,Gattex,teduglutide,12/21/2012,To treat adults with short bowel syndrome (SBS) who need additional nutrition from intravenous feeding (parenteral nutrition).,?,?,,,,7M19191IKG,,,Peptides and glycopeptides(-tide),ATP synthase subunit c,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
1,1,,,,,2005,?,chemical,?,36,Juxtapid,lomitapide,12/21/2012,"To reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH).",?,?,,,,82KUB0583F,,,,Glucagon-like peptide 2 receptor,ALIMENTARY TRACT AND METABOLISM,INN|NPC informatics|Structure undefined,US Approved Rx
,1,,,1,1,2008,?,chemical,?,32,Iclusig,ponatinib,12/14/2012,"To treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.",?,?,,,,4340891KFS,,,Tyrosine-kinase inhibitors(-tinib),Microsomal triglyceride transfer protein large subunit,CARDIOVASCULAR SYSTEM,,US Approved Rx
1,1,1,,1,,2003,?,protein,?,33,raxibacumab,raxibacumab,12/14/2012,"To treat inhalational anthrax, a form of the infectious disease caused by breathing in the spores of the bacterium Bacillus anthracis.",?,?,,,,794PGL549S,,,Monoclonal antibodies(-mab),Breakpoint cluster region protein|Tyrosine-protein kinase ABL1,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,1,,1,,2001,?,chemical,?,34,Signifor,pasireotide,12/14/2012,To treat Cushing’s disease patients who cannot be helped through surgery,?,?,,,,98H1T17066,,,Peptides and glycopeptides(-tide),,ANTIINFECTIVES FOR SYSTEMIC USE,,US Approved Rx
,1,1,,1,,2005,?,chemical,?,31,Cometriq,cabozantinib,11/29/2012,To treat medullary thyroid cancer that has spread to other parts of the body (metastasized).,?,?,,,,1C39JW444G,,,Tyrosine-kinase inhibitors(-tinib),Somatostatin receptor 1|Somatostatin receptor 2|Somatostatin receptor 3|Somatostatin receptor 5,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",,US Approved Rx
,,,,,,2003,?,chemical,?,30,Xeljanz,tofacitinib,11/6/2012,"To treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.",?,?,,,,87LA6FU830,,,Tyrosine-kinase inhibitors(-tinib),Hepatocyte growth factor receptor|Proto-oncogene tyrosine-protein kinase receptor Ret|Vascular endothelial growth factor receptor 2,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,"US Unapproved, Marketed"
1,1,1,,,1,?,?,chemical,?,29,Synribo,omacetaxine mepesuccinate,10/26/2012,"To treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.",?,?,,,,6FG8041S5B,,,,Tyrosine-protein kinase JAK1|Tyrosine-protein kinase JAK2|Tyrosine-protein kinase JAK3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,,,,,2003,?,chemical,?,28,Fycompa,perampanel,10/22/2012,To treat partial onset seizures in patients with epilepsy ages 12 years and older.,?,?,,,,H821664NPK,,,,60S ribosomal protein L3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Approved drugs|EMA orphan|HTS amenable drugs|Human approved drugs|NPC informatics|NPC screening|QC spectra,US Approved Rx
1,,,,,,2002,?,protein,?,27,Jetrea,ocriplasmin,10/17/2012,To treat an eye condition called symptomatic vitreomacular adhesion (VMA).,?,?,,,,7V6HE3DM5A,,,,Glutamate receptor ionotropic AMPA,NERVOUS SYSTEM,,US Approved Rx
,,1,,1,,?,?,chemical,?,26,Stivarga,regorafenib,9/27/2012,To treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).,?,?,,,,24T2A1DOYB,,,,,SENSORY ORGANS,,US Approved Rx
,,,,,,2000,?,chemical,?,24,Aubagio,teriflunomide,9/12/2012,For the treatment of adults with relapsing forms of multiple sclerosis (MS).,?,?,,,,1C058IKG3B,,,,Proto-oncogene tyrosine-protein kinase receptor Ret|RAF proto-oncogene serine/threonine-protein kinase|Vascular endothelial growth factor receptor 2,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,1,,?,?,chemical,?,25,Choline C 11 Injection,choline C-11,9/12/2012,A Positron Emission Tomography (PET) imaging agent used to help detect recurrent prostate cancer.,?,?,,,,M4AS4XGD4Q,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,1,,,,,2005,?,chemical,?,23,Bosulif,bosutinib,9/4/2012,"To treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.",?,?,,,,5018V4AEZ0,,,Tyrosine-kinase inhibitors(-tinib),,,,US Approved Rx
,,1,,1,,2007,?,chemical,?,22,Xtandi,enzalutamide,8/31/2012,"To treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.",?,?,,,,93T0T9GKNU,,,,Proto-oncogene tyrosine-protein kinase Src|Tyrosine-protein kinase ABL1,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,ClinicalTrials.gov|HTS amenable drugs|KEGG|NPC informatics|NPC screening,US Approved Rx
1,,,,,,2004,?,protein,?,21,Linzess,linaclotide,8/30/2012,To treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.,?,?,,,,N0TXR0XR5X,,,Peptides and glycopeptides(-tide),Androgen Receptor,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,2004,?,protein,?,20,Neutroval,tbo-filgrastim,8/29/2012,"To reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.",?,?,,,,PVI5M0M1GW,,,,Heat-stable enterotoxin receptor,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,1,,,,?,?,chemical,?,19,Stribild,elvitegravir,8/27/2012,A once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.,?,?,,,,4GDQ854U53,,,Antiviral drug(-vir),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,Approved drugs|Biologics|FDA NDC|FDA approved|FDA drugs@FDA|FDA human approved|Human approved drugs|INN|Japan|UK NHS,US Approved Rx
1,,1,,,,?,?,chemical,?,19,Stribild,cobicistat,8/27/2012,A once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.,?,?,,,,LW2E03M5PG,,,,Cytochrome P450 3A,ANTIINFECTIVES FOR SYSTEMIC USE|VARIOUS,,US Approved Rx
,,,,1,,2001,?,protein,?,18,Zaltrap,ziv-aflibercept,8/3/2012,"For use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.",?,?,,,,15C2VL427D,,,,,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|SENSORY ORGANS,,US Approved Rx
,,,,,,2002,?,chemical,?,17,Tudorza Pressair,aclidinium bromide,7/23/2012,"For the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.",?,?,,,,UQW7UF9N91,,,,Muscarinic acetylcholine receptor M3,RESPIRATORY SYSTEM,,US Approved Rx
,1,,,,1,2005,?,chemical,?,16,Kyprolis,carfilzomib,7/20/2012,"To treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory.",?,?,,,,72X6E3J5AR,,,,26S proteosome,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,?,?,chemical,?,15,Prepopik,sodium picosulfate,7/16/2012,To help cleanse the colon in adults preparing for colonoscopy.,?,?,,,,LR57574HN8,,,,colonic mucosa,ALIMENTARY TRACT AND METABOLISM,Approved drugs|FDA OTC|FDA approved|FDA human approved|Human approved drugs|INN|Japan|KEGG|NPC screening|UK NHS,US Approved Rx
1,,,,,,2004,?,chemical,?,14,Myrbetriq,mirabegron,6/28/2012,To treat adults with overactive bladder.,?,?,,,,MVR3JL3B2V,,,,Beta-3 adrenergic receptor,GENITO URINARY SYSTEM AND SEX HORMONES,,US Approved Rx
1,,,,,,2004,?,chemical,?,13,Belviq,lorcaserin hydrochloride,6/27/2012,For chronic weight management.,?,?,,,,0QJF08GDPE,,,,Serotonin 2c (5-HT2c) receptor,,,US Approved Rx
,,,,1,,2001,?,protein,?,12,Perjeta,pertuzumab,6/8/2012,To treat patients with HER2-positive late-stage (metastatic) breast cancer.,?,?,,,,K16AIQ8CTM,,,Humanized antibody(-zumab)|Monoclonal antibodies(-mab),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,INN|NPC informatics|Structure undefined,US Approved Rx
,1,1,,,,2004,?,protein,?,11,Elelyso,taliglucerase alfa,5/1/2012,"For long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder",?,?,,,,0R4NLX88O4,,,,,ALIMENTARY TRACT AND METABOLISM,,US Approved Rx
,,,,,,2000,?,chemical,?,10,Stendra,avanafil,4/27/2012,To treat erectile dysfunction.,?,?,,,,DR5S136IVO,,,Inhibitor of PDE5 with vasodilator action(-afil),Phosphodiesterase 5A,GENITO URINARY SYSTEM AND SEX HORMONES,KEGG|NPC informatics|Structure undefined|USAN,US Approved Rx
,,,,1,,?,?,chemical,?,9,Amyvid,Florbetapir F 18,4/6/2012,Used as a radioactive diagnostic agent for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.,?,?,,,,6W15Z5R0RU,,,,,VARIOUS,,US Approved Rx
,,,,,,2004,?,protein,?,8,Omontys,peginesatide,3/27/2012,"To treat anemia, a condition in which the body does not have enough healthy red blood cells, in adult dialysis patients who have chronic kidney disease (CKD).",?,?,,,,JX56W9N61Q,,,Peptides and glycopeptides(-tide),Erythropoietin receptor,BLOOD AND BLOOD FORMING ORGANS,,US Approved Rx
,,,,,,1994,?,protein,?,7,Surfaxin,sinapultide,3/6/2012,"For the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.",?,?,,,,040X3AX99T,,,Peptides and glycopeptides(-tide),,,Approved drugs|Biologics|EMA orphan|Human approved drugs|INN|NPC informatics|Tariff,"US Unapproved, Marketed"
,,,,,,2000,?,chemical,?,6,Zioptan,tafluprost,2/10/2012,For reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.,?,?,,,,1O6WQ6T7G3,,,Prostaglandin analogue(-prost-),Prostanoid FP receptor,SENSORY ORGANS,Approved drugs|ClinicalTrials.gov|HTS amenable drugs|Human approved drugs|INN|Japan|NPC informatics,US Approved Rx
1,1,1,,1,,2006,?,chemical,?,5,Kalydeco,ivacaftor,1/31/2012,For the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene.,?,?,,,,1Y740ILL1Z,,,,Cystic fibrosis transmembrane conductance regulator,RESPIRATORY SYSTEM,,US Approved Rx
1,,1,,1,,2007,?,chemical,?,4,Erivedge,vismodegib,1/30/2012,"To treat adult patients with basal cell carcinoma, the most common type of skin cancer.",?,?,,,,25X868M3DS,,,,Smoothened homolog,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
,,,,,,2004,?,chemical,?,3,Inlyta,axitinib,1/27/2012,To treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.,?,?,,,,C9LVQ0YUXG,,,Tyrosine-kinase inhibitors(-tinib),,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,,US Approved Rx
1,,,,,,2004,?,chemical,?,2,Picato,ingenol mebutate,1/23/2012,For the topical treatment of actinic keratosis.,?,?,,,,7686S50JAH,,,,,DERMATOLOGICALS,,US Approved Rx
1,1,1,,1,,2004,?,protein,?,1,Voraxaze,glucarpidase,1/17/2012,To treat patients with toxic levels of methotrexate in their blood due to kidney failure.,?,?,,,,2GFP9BJD79,,,,Methotrexate,VARIOUS,Approved drugs|Biologics|EMA orphan|Human approved drugs|NPC informatics,US Approved Rx
